Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Doubled survival in metastatic lung cancer with combination therapy

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Doubled survival in metastatic lung cancer with combination therapy ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer ( Dr Leena Gandhi - NYU Langone Medical Center, New York, USA )
25 Apr 2018

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA
Results from CheckMate-227 :  Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )
25 Apr 2018

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018

6-factor prognostic model for patients with advanced urothelial carcinoma

Dr Gregory Pond - McMaster University, Hamilton, Ontario
6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )
9 Feb 2018

Comment: Urothelial cancer research from ASCO GU 2018

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA
Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )
9 Feb 2018

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis

Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK
VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )
9 Feb 2018

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium
Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )
9 Feb 2018

Neoadjuvant and adjuvant therapy in triple negative breast cancer

Prof Banu Arun - MD Anderson Center, Houston, USA
Neoadjuvant and adjuvant therapy in triple negative breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )
25 Jan 2018

The DESKTOPIII trial in platinum-sensitive ovarian cancer

Prof Sean Kehoe - University of Birmingham, Birmingham, UK
The DESKTOPIII trial in platinum-sensitive ovarian cancer ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )
24 Jan 2018

Developing drugs for personalised medicine

Prof Simon Hollingsworth - AstraZeneca, Cambridge, UK
Developing drugs for personalised medicine ( Prof Simon Hollingsworth - AstraZeneca, Cambridge, UK )
14 Dec 2017

Why we are not ready for personalised medicine

Prof Tito Fojo - Columbia University, New York, USA
Why we are not ready for personalised medicine ( Prof Tito Fojo - Columbia University, New York, USA )
11 Dec 2017